In last week's WCMR 'Research in Progress' meeting, we heard from Dr Chun Chen who talked about her project that involves using imaging mass cytometry to analyse mitochondrial dysfunction in…

In this week's WCMR 'Research in Progress' meeting, we heard from Dr Viviana De Luca. The purpose of her research project is to identify and characterise natural compounds that promote…

There are still many unanswered questions about mitochondrial disease despite growing research activity in the UK and across the globe. Funding for research is limited, so it is essential that…

Earlier this year, we were delighted to share the news that WCMR PhD student Laura Smith, who is funded by The Ryan Stanford Appeal, won the Gowers Medical Student Award…

The first talk of our new WCMR 'Research in Progress' seminar series for 2019-20 was given by Dr Brendan Payne. In his talk, Dr Payne described a new model which…

The AIMM (Acipimox in Mitochondrial Myopathy) trial is a clinical trial to determine whether a drug, acipimox, can be used to improve muscle symptoms in patients with mitochondrial myopathy (muscle…

Earlier this week, the Wellcome Centre for Mitochondrial Research (WCMR) at Newcastle University announced its search to appoint a new Director as successor to Professor Sir Doug Turnbull.  This is…

Last month, we were delighted to welcome Dr Bette Phimister, Deputy Editor in Chief at New England Journal of Medicine (NEJM), to the WCMR at Newcastle University. During her visit,…

Idebenone is a drug used in the treatment of Leber’s hereditary optic neuropathy (LHON), a mitochondrial disorder that causes vision loss. LHON usually starts with blurred vision in one or…

At the last Young Scientist meeting, PhD students Gareth Ettridge and Polly Usher tackled the topic of drug screening and drug discovery. The session was based around explaining how new…